Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Medicare’s Proposed Coverage for Alzheimer’s Scan Could Be Boon for Eisai/Biogen
BioSpace
Tue, 07/18/23 - 11:36 am
Tags:
CMS, Alzheimer's disease, Eisai, Biogen, PET scans
Why new Alzheimer’s drugs are in for a tepid launch
Medical Marketing and Media
Sun, 07/16/23 - 03:11 pm
Tags:
Alzheimer's disease, drug launches, Biogen, Eisai, Leqembi
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Motley Fool
Thu, 07/13/23 - 10:16 am
Tags:
Biogen, Eisai, Leqembi, Alzheimer's disease
How will the price of Eisai and Biogen's Leqembi impact Medicare? Sen. Sanders wants to know
Fierce Pharma
Wed, 07/12/23 - 11:03 pm
Tags:
Eisai, Biogen, Leqembi, drug pricing, Medicare, Alzheimer's disease
Following in Biogen's wake, BrainStorm analyzes effect of ALS cell therapy on biomarker
Fierce Biotech
Fri, 07/7/23 - 08:40 am
Tags:
BrainStorm Cell Therapeutics, ALS, cell therapy, Biogen, NurOwn
Leqembi Wins Full FDA Approval as First Anti-Amyloid Antibody for Alzheimer’s
BioSpace
Thu, 07/6/23 - 10:08 pm
Tags:
Biogen, Eisai, Leqembi, FDA, Alzheimer's disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
Tags:
FDA, Eisai, Biogen, Leqembi, Alzheimer's disease, SAGE Therapeutics, zuranolone, postpartum depression, major depressive disorder, Roche, Tecentriq, non-small cell lung cancer, CRISPR Therapeutics, Bluebird Bio, lovo-cel, exa-cel, BrainStorm Cell Therapeutics, NurOwn
Biogen shareholders vote in Susan Langer as director despite relationship with former board member
Fierce Pharma
Mon, 06/26/23 - 08:42 pm
Tags:
Biogen, shareholders
5 FDA decisions to watch in the third quarter
BioPharma Dive
Mon, 06/26/23 - 10:04 am
Tags:
FDA, SAGE Therapeutics, Biogen, zuranolone, Eisai, Leqembi, Sanofi, AstraZeneca, nirsevimab, Iveric Bio, Zimura, Alnylam, Onpattro
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Motley Fool
Fri, 06/23/23 - 10:03 am
Tags:
Biogen, Eisai, Alzheimer's disease, FDA, Leqembi
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Tags:
Roche, Angelman Syndrome, antisense, Biogen, Ionis Pharmaceuticals, Ultragenyx, rugonersen
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Motley Fool
Mon, 06/19/23 - 10:21 am
Tags:
Eisai, Biogen, Leqembi, Alzheimer's disease, Europe
On the Cusp of Full Approval, Leqembi’s Rollout Could Face Challenges
BioSpace
Fri, 06/16/23 - 10:01 am
Tags:
Eisai, Biogen, Alzheimer's disease, FDA, Leqembi
The Biggest Barrier To New Anti-Alzheimer’s Drugs May Be Cost, Not Medicare Rules
Forbes
Wed, 06/14/23 - 06:42 pm
Tags:
Alzheimer's disease, drug pricing, Medicare, Biogen, Eisai, Leqembi
Biogen teams with NeuroSense to explore ALS neurofilament biomarker
BioSpace
Wed, 06/14/23 - 11:35 am
Tags:
Biogen, NeuroSense Therapeutics, ALS, PrimeC
Biogen Makes Changes to Board of Directors Ahead of Annual Shareholder Meeting
BioSpace
Tue, 06/13/23 - 10:44 am
Tags:
Biogen
How ALS Cell Models That Began In Blood Spurred An Encouraging Early-Stage Clinical Trial
Forbes
Mon, 06/12/23 - 10:08 am
Tags:
clinical trials, innovation, ALS, Parkinson's Disease, Biogen
FDA panel backs full approval for Eisai, Biogen Alzheimer’s drug
BioPharma Dive
Sun, 06/11/23 - 11:14 pm
Tags:
Eisai, Biogen, Leqembi, FDA, Alzheimer's disease
Eisai files Leqembi in Korea, as US prospects firm up
Pharmaphorum
Thu, 06/8/23 - 10:02 am
Tags:
Eisai, Biogen, Leqembi, Alzheimer's disease, South Korea, Asia
Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 06/7/23 - 09:53 pm
Tags:
FDA, Eisai, Biogen, Leqembi, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.